news Attenuated vaccine could combat fatal Leptospira bacteria 27 January 2021 | By Hannah Balfour (Drug Target Review) A single vaccination with a mutated Leptospira bacteria prevented rodent models from developing leptospirosis, the most fatal type of zoonotic disease worldwide.
news Novel antimicrobial molecules derived from wasp venom 13 October 2020 | By Hannah Balfour (Drug Target Review) Altering the mastoparan-L (mast-L) peptide found in Vespula lewisii wasp venom, researchers created several novel antimicrobial molecules.
news Researchers uncover drivers of memory B cell formation 13 October 2020 | By Hannah Balfour (Drug Target Review) The team demonstrated that expression of Bach2 protein and reduced mTORC1 activity is necessary for germinal B cells to become memory B cells.
news Novel GI tract coating could deliver drugs, aid digestion or control obesity 27 August 2020 | By Hannah Balfour (Drug Target Review) The developers of a temporary coating which adheres to the small intestine demonstrated it could be modified to deliver drugs, aid digestion and stop absorption of glucose.
news Novel tuberculosis transport protein could be target of new treatments 1 April 2020 | By Hannah Balfour (Drug Target Review) Cryogenic electron microscopy revealed that the vitamin B12 transporter on Mycobacterium tuberculosis acts like a non-selective sluice, transporting both the vitamin and antibiotics.
news Cannabidiol identified as potential ‘helper’ compound for antibiotics 25 March 2020 | By Victoria Rees (Drug Target Review) Researchers have found that using antibiotics in combination with cannabidiol (CBD) enhanced their effect against Staphylococcus aureus bacteria.
news CRISPR-Cas3 used to combat C. difficile in lab and mice 11 March 2020 | By Victoria Rees (Drug Target Review) Researchers have shown that CRISPR-Cas3 can successfully attack C. difficile in vitro and in mice, by causing DNA damage to the pathogen.
news Blocking bacterial competence could prevent antibiotic resistance 4 March 2020 | By Hannah Balfour (Drug Target Review) Scientists suggest competence-blocking, ‘anti-evolution’ drugs could be administered alongside antibiotics to prolong the period before bacterial resistance emerges.
news Novel antibody breaks bacterial biofilms and prevents sepsis in mice 2 March 2020 | By Victoria Rees (Drug Target Review) A new monoclonal antibody has been discovered which disassociates bacterial biofilms and stops bacteria from entering into circulation has been tested in mice.
news Metal-containing compounds could lead to new antibacterials 2 March 2020 | By Hannah Balfour (Drug Target Review) International collaboration has shown that compounds with metals in them show antibacterial activity against MRSA, E. coli and A. baumannii.
news Study reveals how immune system handles fungal and viral infections 28 February 2020 | By Victoria Rees (Drug Target Review) Researchers have studied how the human body responds to viral infection when already infected by fungi, offering insights into the immune system.
news New T-cell discovery could lead to treatments for both bacterial infections and autoimmune conditions 28 February 2020 | By Hannah Balfour (Drug Target Review) A novel highly activated form of T cells could be suppressed to treat autoimmune conditions and activated in treating bacterial infections.
news Secret life of antimicrobial peptide revealed through CRISPR 26 February 2019 | By Drug Target Review Antimicrobial peptides were found to act against Gram-negative bacteria and certain fungi by working either together or by adding up their individual effects...
news Peptide research gives insight on tackling bacteria 29 January 2019 | By Drug Target Review Researchers have paved the path towards redesigning antibiotics through the alteration of the peptide assembly involved in the process...
news Naturally occurring potent antibiotic revealed 18 January 2019 | By Iqra Farooq (Drug Target Review) A natural antibiotic was found to be made from an enzyme, through it triggering chemical reactions that help the production of the bacterial toxin...